BNP PARIBAS FINANCIAL MARKETS - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 56 filers reported holding ONCOCYTE CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2023$958
-35.1%
4,1640.0%0.00%
Q1 2023$1,476
-7.5%
4,164
-16.2%
0.00%
Q4 2022$1,595
-100.0%
4,969
-20.7%
0.00%
Q3 2022$4,576,000
-61.6%
6,269
-52.7%
0.00%
Q2 2022$11,927,000
-78.8%
13,257
-64.9%
0.00%
Q1 2022$56,295,000
-39.0%
37,782
-11.2%
0.00%
Q4 2021$92,312,000
+129.9%
42,540
+277.2%
0.00%
Q3 2021$40,150,000
+184.4%
11,278
+358.6%
0.00%
Q2 2021$14,115,000
-70.0%
2,459
-72.9%
0.00%
Q1 2021$47,016,000
+22.7%
9,059
-43.5%
0.00%
Q4 2020$38,312,000
+78.1%
16,030
+3.6%
0.00%
Q3 2020$21,512,000
+323.2%
15,476
+481.6%
0.00%
Q2 2020$5,083,000
-69.1%
2,661
-60.4%
0.00%
Q1 2020$16,457,000
+146.8%
6,717
+126.7%
0.00%
Q4 2019$6,667,000
+200.3%
2,963
+180.3%
0.00%
Q3 2019$2,220,000
+1119.8%
1,057
+1347.9%
0.00%
Q2 2019$182,000
-70.6%
73
-53.5%
0.00%
Q1 2019$620,000
+185.7%
1570.0%0.00%
Q4 2018$217,000
-44.6%
1570.0%0.00%
Q3 2018$392,000
-2.0%
1570.0%0.00%
Q2 2018$400,000
-77.1%
157
-81.2%
0.00%
Q1 2018$1,749,000
-49.6%
833
+11.7%
0.00%
Q4 2017$3,469,000
+30.9%
746
+112.5%
0.00%
Q3 2017$2,650,000
+35.2%
351
-6.9%
0.00%
Q2 2017$1,960,000
+260.3%
377
+219.5%
0.00%
Q1 2016$544,0001180.00%
Other shareholders
ONCOCYTE CORP shareholders Q2 2019
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 3,596,680$27,155,0004.50%
Family Management Corp 20,550$155,0000.11%
Artal Group S.A. 150,000$1,133,0000.02%
Destination Wealth Management 29,656$224,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 145,000$1,095,0000.01%
Carroll Financial Associates, Inc. 850$5,0000.00%
Advisor Group, Inc. 112$1,0000.00%
FIFTH THIRD BANCORP 210$2,0000.00%
HUNTINGTON NATIONAL BANK 10$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 2,413$18,0000.00%
View complete list of ONCOCYTE CORP shareholders